Clinical Trials Logo

Filter by:
NCT ID: NCT06459596 Recruiting - Clinical trials for Diabetes Mellitus, Type 2

Pilot Brief Communal Coping Intervention for Adults With Type 2 Diabetes

Start date: November 22, 2022
Phase: N/A
Study type: Interventional

The investigators plan to develop a communal coping intervention aimed at instilling a shared appraisal of diabetes and increasing patient-partner collaboration. To that end, the investigators will pilot the first randomized clinical trial of a brief communal coping intervention among couples in which one person has T12

NCT ID: NCT06459401 Completed - Stroke Clinical Trials

Effects of an Overground Propulsion Neuroprosthesis in Community-dwelling Individuals After Stroke

Start date: February 22, 2021
Phase: Early Phase 1
Study type: Interventional

This interventional study evaluates the effects of an overground propulsion neuroprosthesis that delivers adaptive neurostimulation assistance to the paretic plantarflexors and dorsiflexors of people post-stroke. Individuals with chronic post-stroke hemiparesis will walk with and without the neuroprosthesis overground and on a treadmill. The goal of the study is to understand how adaptive neurostimulation delivered by the neuroprosthesis affects clinical and biomechanical measures of walking function in order to guide future rehabilitation approaches for restoring walking ability after stroke.

NCT ID: NCT06459232 Completed - Multiple Sclerosis Clinical Trials

Characteristics, Adherence, and Persistence Among Multiple Sclerosis Patients Treated With Disease-Modifying Therapies

Start date: November 19, 2020
Phase:
Study type: Observational

This retrospective, observational cohort study used administrative claims data contained in the International Business Machines (IBM)® Truven Marketscan® Research Databases to describe demographic, clinical, and treatment characteristics in patients with multiple sclerosis (MS) who were initiated on siponimod, and other Food and Drug Administration (FDA)-approved disease-modifying therapies (DMTs). The study time period was from March 2018 through June 2020 (most recent available data) and included a 1-year baseline period and a variable-length follow-up period (a minimum of 6 months follow-up required for post-index outcomes). The index date was defined as the date of the first claim for siponimod or other MS-specific treatment on or after March 2019. The data analysis was performed on a combination of early view and standard view data. The initial data analysis was from Standard Marketscan data used for patients with index data prior to the year 2019. Both standard view and early view data were used for patients indexed after January 1, 2019. The early view data provided additional visibility as it contains an additional 2 quarters of data compared to standard data.

NCT ID: NCT06459206 Recruiting - Hypoxia Clinical Trials

Accuracy of the EvieMED Ring Pulse Oximeter in Profound Hypoxia

Start date: June 11, 2024
Phase:
Study type: Observational [Patient Registry]

The goal of this study was to evaluate the accuracy of pulse oximeters over the range of 70-100% per the International Organization for Standardization (ISO) 80601-2-61:2019. Four test devices were placed on each subject on the left or right hand with two at the finger base and two at the fingertip. Motion equipment was used to control motion of the test devices. In addition, two test devices were placed on the contralateral hand on the base of a finger and also on the fingertip. Finally, a test wrist device was placed on either the left or right wrist. SpO2 measurements from these devices were compared to sampling of arterial blood during brief stable oxygen desaturation in healthy volunteers to evaluate the claimed range.

NCT ID: NCT06458998 Not yet recruiting - Cirrhosis Clinical Trials

Getting To Implementation: Improving Cancer Screening for Veterans

GTI
Start date: July 15, 2024
Phase: N/A
Study type: Interventional

Gastrointestinal cancers such as colon cancer and liver cancer cause many deaths in the US. Testing could catch these cancers early, helping people live longer. The goal of this study is to compare two different ways of getting more people tested for these cancers: 1) by directly reaching out to the people who need testing or 2) by helping providers fix issues that hold up testing. The main question it aims to answer is: how should healthcare systems go about choosing one or the other? Researchers will look at cancer testing rates over time at sites that are trying these different approaches. They will also survey and interview participants from these sites.

NCT ID: NCT06458985 Recruiting - Opioid Use Disorder Clinical Trials

Disclosure Intervention for People in Treatment for Opioid Use Disorder

Start date: May 20, 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to test a disclosure intervention among people in treatment for opioid use disorder. The main question it aims to answer is whether people who receive a disclosure intervention have better treatment- and recovery-related outcomes one year after receiving the intervention. Participants will complete a brief disclosure intervention designed to help them (1) make key disclosures related to disclosure and (2) build skills to disclose. Researchers will compare results to participants in a waitlist comparator condition, who receive the intervention at the end of the study.

NCT ID: NCT06458946 Recruiting - Blood Glucose Clinical Trials

Monitoring Postprandial Blood Glucose and Insulin in Fruit Snacks

Start date: May 22, 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare the postprandial glucose and insulin responses after different fruit snacks compared to confection control in a healthy population

NCT ID: NCT06458920 Recruiting - Emotion Regulation Clinical Trials

Social Facilitation of Emotion Regulation in Adolescence

Start date: October 5, 2022
Phase: N/A
Study type: Interventional

The goal of this project is to test whether regulating emotions with help from a friend is more effective and long-lasting in adolescents than regulating alone, and to characterize age-related differences in the neural mechanisms supporting social versus cognitive emotion regulation. Participants will complete a psychology experiment while undergoing fMRI scanning.

NCT ID: NCT06458907 Not yet recruiting - Clinical trials for Tricuspid Regurgitation

TRICAV-II Pivotal: TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation.

TRICAV-II
Start date: December 2024
Phase: N/A
Study type: Interventional

The Investigational Device is the TricValve Transcatheter Bicaval Valve System (also referred to as the TricValve System). The bioprosthesis is available in two different diameters for each model (SVC and IVC) specifically designed to adapt to the anatomic features of the superior and inferior vena cava. The SVC and IVC valves are single use, sterile devices provided in two sizes each, for a total of four valve sizes. The valves are designed for heterotopic caval implantation without perturbing the native tricuspid valve. The valves are made of bovine pericardium leaflets sutured on a nitinol self-expanding stent system. The SVC and IVC valves are provided pre-mounted in two separate TricValve Delivery Systems, and are individually packaged into two separate boxes, provided sterile and ready to use. The two TricValve Delivery Systems deliver the two valves percutaneously into the SVC and IVC via femoral vein access using a transvenous approach.

NCT ID: NCT06458790 Not yet recruiting - Obesity, Childhood Clinical Trials

Black Resilient Caregivers

AARC
Start date: August 1, 2024
Phase: N/A
Study type: Interventional

To determine the feasibility of an intervention to promote the physical and socioemotional health of African American (AA) families.